Menactra: information updated on Guillain Barre syndrome

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1561, 2006-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Menactra: information updated on Guillain Barre syndrome

By  

Reactions Weekly, Vol. 1, Iss. 1125, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Vaccines linked to Guillain-Barre syndrome

By  

Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Treatment of Guillain-Barre Syndrome: A Review

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 330-334

Bentham Science Publishers

Access to resources Recommend Favorite

Efalizumab: Guillain-Barre syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Infliximab: Guillain-Barre syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite